{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:33:15Z","timestamp":1789842795460,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05860-2","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:37:19Z","timestamp":1787791039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integration of FAERS database and network toxicology to investigate adverse drug events and potential toxicological mechanisms of triazole antifungal agents"],"prefix":"10.1007","author":[{"given":"Bangtian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"5860_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101363","volume":"104","author":"M Bassetti","year":"2025","unstructured":"Bassetti M, Vena A (2025) Invasive fungal infections: an expanding and evolving threat. Mol Aspects Med 104:101363. https:\/\/doi.org\/10.1016\/j.mam.2025.101363","journal-title":"Mol Aspects Med"},{"key":"5860_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/20420986221143266","volume":"13","author":"S Chai","year":"2022","unstructured":"Chai S, Zhan JL, Zhao LM, Liu XD (2022) Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS. Ther Adv Drug Saf 13:20420986221143266. https:\/\/doi.org\/10.1177\/20420986221143266","journal-title":"Ther Adv Drug Saf"},{"key":"5860_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1255918","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Xu S, Yu W, Sun C, Zhang W (2024) Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database. Front Pharmacol 15:1255918. https:\/\/doi.org\/10.3389\/fphar.2024.1255918","journal-title":"Front Pharmacol"},{"key":"5860_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19244","volume":"9","author":"J Dong","year":"2023","unstructured":"Dong J, Cui J, Shi X, Wang T, Liu S (2023) Itraconazole inhibits proliferation, induces apoptosis, and reduces angiogenesis of hemangioma endothelial cells by downregulating the hedgehog signaling pathway. Heliyon 9:e19244. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19244","journal-title":"Heliyon"},{"issue":"1","key":"5860_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","volume":"30","author":"W Fang","year":"2023","unstructured":"Fang W, Wu J, Cheng M, Zhu X, Du M, Chen C, Liao W, Zhi K, Pan W (2023) Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci 30(1):42. https:\/\/doi.org\/10.1186\/s12929-023-00926-2","journal-title":"J Biomed Sci"},{"key":"5860_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1578749","volume":"16","author":"Y Feng","year":"2025","unstructured":"Feng Y, Feng W, Yang J, Ma Y (2025) Exploring the therapeutic mechanism of itraconazole combined with ritonavir on Candida albicans infection through network pharmacology and molecular docking. Front Pharmacol 16:1578749. https:\/\/doi.org\/10.3389\/fphar.2025.1578749","journal-title":"Front Pharmacol"},{"issue":"11","key":"5860_CR7","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1517\/17425255.2011.627854","volume":"7","author":"PO Gubbins","year":"2011","unstructured":"Gubbins PO (2011) Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450. Expert Opin Drug Metab Toxicol 7(11):1411\u20131429. https:\/\/doi.org\/10.1517\/17425255.2011.627854","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"5860_CR8","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00204-016-1757-0","volume":"90","author":"O Karlsson","year":"2016","unstructured":"Karlsson O, Lindquist NG (2016) Melanin and neuromelanin binding of drugs and chemicals: toxicological implications. Arch Toxicol 90(8):1883\u20131891. https:\/\/doi.org\/10.1007\/s00204-016-1757-0","journal-title":"Arch Toxicol"},{"issue":"1","key":"5860_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13256-025-05321-z","volume":"19","author":"S Kim","year":"2025","unstructured":"Kim S, Chen K, Stull W (2025) Fluconazole-induced drug rash with eosinophilia and systemic symptoms syndrome: a case report. J Med Case Rep 19(1):257. https:\/\/doi.org\/10.1186\/s13256-025-05321-z","journal-title":"J Med Case Rep"},{"issue":"2","key":"5860_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14740338.2017.1270264","volume":"16","author":"I Kyriakidis","year":"2017","unstructured":"Kyriakidis I, Tragiannidis A, Munchen S, Groll AH (2017) Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf 16(2):149\u2013165. https:\/\/doi.org\/10.1080\/14740338.2017.1270264","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"5860_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/exd.14038","volume":"29","author":"V Lee","year":"2020","unstructured":"Lee V, Gober MD, Bashir H, O\u2019Day C, Blair IA, Mesaros C, Weng L, Huang A, Chen A, Tang R et al (2020) Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress. Exp Dermatol 29(1):29\u201338. https:\/\/doi.org\/10.1111\/exd.14038","journal-title":"Exp Dermatol"},{"issue":"1","key":"5860_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.151","volume":"4","author":"P Li","year":"2024","unstructured":"Li P, Liu D, Gao P, Yuan M, Zhao Z, Zhang Y, Zhou Z, Zhang Q, Yuan M, Liu X et al (2024) Mitigating ibrutinib-induced ventricular arrhythmia and cardiac dysfunction with metformin. Cancer Innov 4(1):e151. https:\/\/doi.org\/10.1002\/cai2.151","journal-title":"Cancer Innov"},{"key":"5860_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119480","volume":"343","author":"X Li","year":"2025","unstructured":"Li X, Lin L, Pang L, Pu K, Fu J, Shen Y, Zhang W, Xu H, Niu Y (2025) Application and development trends of network toxicology in the safety assessment of traditional Chinese medicine. J Ethnopharmacol 343:119480. https:\/\/doi.org\/10.1016\/j.jep.2025.119480","journal-title":"J Ethnopharmacol"},{"key":"5860_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1420046","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, Huang Y, Liu X, Wang D, Hu Y (2024) Characteristics of voriconazole-induced visual disturbances and hallucinations: case reports and literature review. Front Pharmacol 15:1420046. https:\/\/doi.org\/10.3389\/fphar.2024.1420046","journal-title":"Front Pharmacol"},{"issue":"4","key":"5860_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.medcli.2024.01.045","volume":"163","author":"M Machado","year":"2024","unstructured":"Machado M, Fortun J, Munoz P (2024) Invasive aspergillosis: a comprehensive review. Med Clin (Barc) 163(4):189\u2013198. https:\/\/doi.org\/10.1016\/j.medcli.2024.01.045","journal-title":"Med Clin (Barc)"},{"issue":"10273","key":"5860_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","volume":"397","author":"JA Maertens","year":"2021","unstructured":"Maertens JA, Rahav G, Lee DG, Ponce-de-Leon A, Ramirez Sanchez IC, Klimko N, Sonet A, Haider S, Diego Velez J, Raad I et al (2021) Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet 397(10273):499\u2013509. https:\/\/doi.org\/10.1016\/S0140-6736(21)00219-1","journal-title":"Lancet"},{"issue":"10","key":"5860_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/phar.2850","volume":"43","author":"EK McCreary","year":"2023","unstructured":"McCreary EK, Davis MR, Narayanan N, Andes DR, Cattaneo D, Christian R, Lewis RE, Watt KM, Wiederhold NP, Johnson MD (2023) Utility of triazole antifungal therapeutic drug monitoring: insights from the Society of Infectious Diseases Pharmacists: endorsed by the Mycoses Study Group Education and Research Consortium. Pharmacotherapy 43(10):1043\u20131050. https:\/\/doi.org\/10.1002\/phar.2850","journal-title":"Pharmacotherapy"},{"issue":"2","key":"5860_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaci.2015.06.024","volume":"136","author":"AW Michels","year":"2015","unstructured":"Michels AW, Ostrov DA (2015) New approaches for predicting T cell-mediated drug reactions: a role for inducible and potentially preventable autoimmunity. J Allergy Clin Immunol 136(2):252\u2013257. https:\/\/doi.org\/10.1016\/j.jaci.2015.06.024","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"5860_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/09246479251325475","volume":"36","author":"PC Ntoutoume Nzoghe","year":"2025","unstructured":"Ntoutoume Nzoghe PC, Lakhmiri R, Coniquet S, Missounga L, Ntsame S, Cherrah Y, Serragui S (2025) Fluconazole-induced Stevens-Johnson syndrome at Libreville University Hospital - Gabon: a case report. Int J Risk Saf Med 36(3):134\u2013140. https:\/\/doi.org\/10.1177\/09246479251325475","journal-title":"Int J Risk Saf Med"},{"issue":"3","key":"5860_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/biology11030372","volume":"11","author":"A Roberti","year":"2022","unstructured":"Roberti A, Chaffey LE, Greaves DR (2022) NF-kappaB signaling and inflammation-drug repurposing to treat inflammatory disorders? Biology 11(3):372. https:\/\/doi.org\/10.3390\/biology11030372","journal-title":"Biology"},{"issue":"7","key":"5860_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, Tamon A, Kadoyama K, Okuno Y (2013) Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 10(7):796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048","journal-title":"Int J Med Sci"},{"issue":"1","key":"5860_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/08923973.2019.1566357","volume":"41","author":"GS Silva","year":"2019","unstructured":"Silva GS, Zuravski L, Duarte M, Machado MM, Oliveira LFS (2019) Fluconazole induces genotoxicity in cultured human peripheral blood mononuclear cells via immunomodulation of TNF-alpha, IL-6, and IL-10: new challenges for safe therapeutic regimens. Immunopharmacol Immunotoxicol 41(1):123\u2013129. https:\/\/doi.org\/10.1080\/08923973.2019.1566357","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"5860_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2025.100341","volume":"8","author":"CM Souza","year":"2025","unstructured":"Souza CM, Bezerra BT, Mellon DA, de Oliveira HC (2025) The evolution of antifungal therapy: traditional agents, current challenges and future perspectives. Curr Res Microb Sci 8:100341. https:\/\/doi.org\/10.1016\/j.crmicr.2025.100341","journal-title":"Curr Res Microb Sci"},{"issue":"8","key":"5860_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/14787210.2016.1199272","volume":"14","author":"FP Tverdek","year":"2016","unstructured":"Tverdek FP, Kofteridis D, Kontoyiannis DP (2016) Antifungal agents and liver toxicity: a complex interaction. Expert Rev Anti Infect Ther 14(8):765\u2013776. https:\/\/doi.org\/10.1080\/14787210.2016.1199272","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5860_CR25","unstructured":"U.S. Department of Health and Human Services (2025) FDA adverse event reporting system (FAERS) quarterly data extract files. Available at: https:\/\/fis.fda.gov\/extensions\/FPD-QDE-FAERS\/FPD-QDE-FAERS.html"},{"key":"5860_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110661","volume":"131","author":"W Wang","year":"2020","unstructured":"Wang W, Dong X, Liu Y, Ni B, Sai N, You L, Sun M, Yao Y, Qu C, Yin X et al (2020) Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K\/AKT\/mTOR, and ROS pathways. Biomed Pharmacother 131:110661. https:\/\/doi.org\/10.1016\/j.biopha.2020.110661","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"5860_CR27","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s11255-024-03989-8","volume":"56","author":"H Wang","year":"2024","unstructured":"Wang H, Gao L, Zhao C, Fang F, Liu J, Wang Z, Zhong Y, Wang X (2024) The role of PI3K\/Akt signaling pathway in chronic kidney disease. Int Urol Nephrol 56(8):2623\u20132633. https:\/\/doi.org\/10.1007\/s11255-024-03989-8","journal-title":"Int Urol Nephrol"},{"key":"5860_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1529416","volume":"16","author":"S Wang","year":"2025","unstructured":"Wang S, Song L, Sun Y, Zhou H, Yao J (2025) An in-depth exploration of the association between olanzapine, quetiapine and acute pancreatitis based on real-world datasets and network toxicology analysis. Front Pharmacol 16:1529416. https:\/\/doi.org\/10.3389\/fphar.2025.1529416","journal-title":"Front Pharmacol"},{"key":"5860_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1432759","volume":"15","author":"R Xiong","year":"2024","unstructured":"Xiong R, Lei J, Wang L, Zhang S, Liu H, Wang H, Liu T, Lai X (2024) Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example. Front Pharmacol 15:1432759. https:\/\/doi.org\/10.3389\/fphar.2024.1432759","journal-title":"Front Pharmacol"},{"issue":"10","key":"5860_CR30","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1158\/1535-7163.MCT-20-0638","volume":"20","author":"W Zhang","year":"2021","unstructured":"Zhang W, Bhagwath AS, Ramzan Z, Williams TA, Subramaniyan I, Edpuganti V, Kallem RR, Dunbar KB, Ding P, Gong K et al (2021) Itraconazole exerts its antitumor effect in esophageal cancer by suppressing the HER2\/AKT signaling pathway. Mol Cancer Ther 20(10):1904\u20131915. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0638","journal-title":"Mol Cancer Ther"},{"key":"5860_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1039867","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Wei Z, Xu B, Liu M, Xu R, Wu X (2022) Pharmacovigilance of triazole antifungal agents: analysis of the FDA adverse event reporting system (FAERS) database. Front Pharmacol 13:1039867. https:\/\/doi.org\/10.3389\/fphar.2022.1039867","journal-title":"Front Pharmacol"},{"key":"5860_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1415918","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chen J, Xu B, Chen L (2024) Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database. Front Pharmacol 15:1415918. https:\/\/doi.org\/10.3389\/fphar.2024.1415918","journal-title":"Front Pharmacol"},{"key":"5860_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116388","volume":"346","author":"X Zhou","year":"2025","unstructured":"Zhou X, Xiang S, Xu B, Xu J, Long Y, Chen J, Chen L (2025) A scientific approach to hemorrhage risk assessment of SSRIs\/SNRIs utilizing the FAERS database. Psychiatry Res 346:116388. https:\/\/doi.org\/10.1016\/j.psychres.2025.116388","journal-title":"Psychiatry Res"},{"key":"5860_CR34","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/infdis\/jiu017","volume":"209","author":"D Zonios","year":"2014","unstructured":"Zonios D, Yamazaki H, Murayama N, Natarajan V, Palmore T, Childs R, Skinner J, Bennett JE (2014) Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype. J Infect Dis 209:1941\u20131948. https:\/\/doi.org\/10.1093\/infdis\/jiu017","journal-title":"J Infect Dis"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05860-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05860-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05860-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:02:35Z","timestamp":1787835755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05860-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":34,"alternative-id":["5860"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05860-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}